Ord5tZ4Q8JI https://histock.tw/talk/live.aspx?name=gtalk&id=1325 20250423 阿布波

台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    64.4
  • 漲跌
    ▲1.0
  • 漲幅
    +1.58%
  • 成交量
    47
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
逸達 (6576)籌碼相關-凱基-永康 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-永康 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/160.165.0000.0064.100.12100.05%
2025/04/150.165.40264.5066.00-2209-0.93%
2025/04/140.164.5000.0063.500.12080.02%
2025/04/110.863.4400.0064.400.82070.39%
2025/04/090.258.5500.0057.900.22080.10%
2025/04/080.364.9000.0064.100.32000.15%
2025/04/070.371.2000.0071.200.31920.16%
2025/03/280.181.50281.3581.60-2203-0.96%
2025/03/25083.7000.0083.4002030.00%
2025/03/240.183.8600.0083.500.12070.02%
2025/03/2000.00382.8083.00-3199-1.51%
2025/03/14183.1000.0083.5012020.49%
2025/03/110.183.8000.0084.200.12030.02%
2025/03/04184.5000.0084.8012100.48%
2025/02/1700.00386.7086.30-3226-1.32%
2025/02/1200.00184.5083.50-1217-0.46%
2025/01/0300.00178.1077.20-1190-0.53%
2024/12/110.173.75172.7073.80-0.9158-0.57%
2024/12/1000.00175.2073.40-1156-0.64%
2024/12/090.175.9000.0075.400.11490.03%
2024/12/060.177.5000.0077.000.11410.04%
2024/12/040.277.8700.0077.600.21380.17%
2024/11/273.178.3900.0078.303.11262.41%
2024/11/260.178.7000.0079.400.11320.04%
2024/11/2200.00382.0082.00-3121-2.46%
2024/11/140.176.9500.0075.800.11040.10%
2024/11/120.176.5800.0076.000.11070.09%
2024/11/110.177.6000.0076.700.11080.09%
2024/11/070.176.6000.0076.100.11030.05%
2024/10/280.178.5000.0078.000.11260.04%
2024/10/25079.7000.0078.9001310.00%
2024/10/221.176.6200.0076.801.11370.80%
2024/10/211.177.8500.0077.801.11390.79%
2024/10/140.180.0000.0079.700.11540.06%
2024/10/110.180.5000.0080.200.11570.06%
2024/10/070.182.3000.0082.300.11640.06%
2024/09/230.183.0000.0082.200.12010.05%
2024/09/2000.00381.1081.70-3207-1.45%
2024/09/180.180.5000.0079.800.12440.02%
2024/09/130.180.0000.0080.100.12480.02%
2024/09/040.178.7000.0078.900.12720.04%
2024/08/3000.00182.0081.70-1290-0.34%
2024/08/290.182.5000.0082.000.12950.03%
2024/08/2200.00279.6079.70-2293-0.68%
2024/08/12179.9000.0079.6012970.34%
2024/08/06272.05168.8072.0013010.33%
2024/08/05672.55375.4072.5032991.00%
2024/08/0200.00279.2079.50-2291-0.69%
2024/07/2900.00279.6079.50-2289-0.69%
2024/07/16182.8000.0083.2012770.36%
2024/07/09184.6000.0083.6012800.36%
2024/06/28183.2000.0083.5012700.37%
2024/06/25681.5800.0083.5062602.30%
2024/06/07399.9000.0099.6032201.36%
2024/05/06194.0000.0094.6013180.31%
2024/04/30295.6500.0095.9023190.63%
2024/04/25194.6000.0095.1013190.31%
逸達兒童中樞性早熟三期臨床 三度獲DSMB正面回饋持續進行Anue鉅亨-2025/02/17
逸達受美國經銷商指示不定期出貨 1月營收年減逾6成Anue鉅亨-2025/02/08
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-2025/01/14
逸達 相關文章
逸達 相關影音